Keywords: pfizer, pipeline, down, six, months, ago, part

Pfizer's R&D pipeline down 12% on six months ago as part of new focus high-priority areas

Article | 03 April 2009

Print This

Pfizer, the world's largest R&D-based drugmaker by sales, says that the number of drugs in its development pipeline has ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in